U.S. Markets closed

CorMedix Inc. (CRMD)

NYSE American - NYSE American Delayed Price. Currency in USD
Add to watchlist
Visitors trend2W10W9M
8.64+0.01 (+0.12%)
At close: 4:00PM EST
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Annual
Quarterly
Premium required to access monthly data
Monthly
Subscribe to Premium to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 2.73
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 39.42
52 Week Low 32.16
50-Day Moving Average 38.25
200-Day Moving Average 36.16

Share Statistics

Avg Vol (3 month) 3380.71k
Avg Vol (10 day) 3415.64k
Shares Outstanding 532.13M
Float 29.91M
% Held by Insiders 12.04%
% Held by Institutions 126.16%
Shares Short (Dec 30, 2020) 43.05M
Short Ratio (Dec 30, 2020) 47.32
Short % of Float (Dec 30, 2020) 49.63%
Short % of Shares Outstanding (Dec 30, 2020) 49.49%
Shares Short (prior month Nov 29, 2020) 43.28M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:5
Last Split Date 3Mar 25, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Sep 29, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-12,728.07%

Management Effectiveness

Return on Assets (ttm)-44.94%
Return on Equity (ttm)-67.25%

Income Statement

Revenue (ttm)208.29k
Revenue Per Share (ttm)0.01
Quarterly Revenue Growth (yoy)56.30%
Gross Profit (ttm)-89.97k
EBITDA -26.45M
Net Income Avi to Common (ttm)-21.24M
Diluted EPS (ttm)-0.79
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)37.04M
Total Cash Per Share (mrq)1.15
Total Debt (mrq)1.05M
Total Debt/Equity (mrq)3.05
Current Ratio (mrq)8.45
Book Value Per Share (mrq)1.10

Cash Flow Statement

Operating Cash Flow (ttm)-19.92M
Levered Free Cash Flow (ttm)-15.28M